Secoo To Implement ADS Ratio Change From From 2:1 To 1:5

Secoo Holding Limited ("Secoo" or the "Company") (NASDAQ:SECO), Asia's leading online integrated upscale products and services platform, today announced that it will change the ratio of its

Secoo Holding Limited (“Secoo” or the “Company”) (NASDAQ:SECO), Asia’s leading online integrated upscale products and services platform, today announced that it will change the ratio of its American depositary shares (“ADSs”) to its Class A ordinary shares (the “ADS Ratio”), par value US$0.001 per share, from the current ratio of two (2) ADSs to one (1) Class A ordinary share to a new ratio of one (1) ADS to five (5) Class A ordinary shares.

Total
0
Shares
Related Posts
Read More

Zentalis To Present Clinical Data In Ovarian Cancer Combining Azenosertib And Chemotherapy, Including Clinical Support For Cyclin E1 Expression As Predictive Marker For Clinical Benefit From Azenosertib At The 2023 ASCO Annual Meeting

Builds on recent preclinical data presented at AACR supporting the use of CCNE1 amplification and / or Cyclin E1 expression as a potential marker for the enrichment of patient populations for treatment with

ZNTL